Galectin Therapeutics Inc. (GALT)

[PaPaGriz]

Knowing Traber, there will not be any compassionate use patients. I believe they think, with much justification, that if anything goes wrong with someone on a compassionate use program, it will negatively affect the stock, possibly VERY negatively.

I want to change my statement (in bold) below. The fact is that even if I knew I could get a transplant, I would want to try GR-MD-02 first.

Quote:
I wonder how the new focus on expanding compassionate use might come into play. GR-MD-02 has successfully completed Phase 1 trials. If I was dying because I could not get a liver transplant, I would be doing everything in my power to get treated with GR-MD-02. - thefamilyman